Skip to content

Clinical trials

Phase 2 Mesothelioma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma Phase: Phase 2 Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20031
20042
20066
20073
20085
20094
20122
20133
20142
20155
20167
20173
20183
20193
20202
20214
20222
20233
20243
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated9
Unknown status9
Active, not recruiting7
Recruiting6
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
Memorial Sloan Kettering Cancer Center4
Bayer2
Columbia University2
Dana-Farber Cancer Institute2
Eli Lilly and Company2
Novartis Pharmaceuticals2
University of Chicago2
Wales Cancer Trials Unit2
AHS Cancer Control Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma70
Mesothelioma, Malignant21
Lung Neoplasms9
Sarcoma6
Cholangiocarcinoma5
Small Cell Lung Carcinoma5
Carcinoma, Renal Cell4
Stomach Neoplasms4
Thyroid Neoplasms4
Anus Neoplasms3

Trials

Showing 76 to 70 of 70. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.